These compounds may interact with:
5-hydroxytryptamine receptor 1D
Potentially involved in: migraine; obsessive-compulsive disorder; neurodegeneration with brain iron accumulation 5; autistic disorder; depressive disorder; hypotension; schizophrenia; diabetes mellitus; malignant mesothelioma; major depressive disorder; cluster headache syndrome; vascular headache; cluster headache prevention
Disease data sourced from Pharos.